Haleon Plc: 2024 Half Year Results Summary (Form 6-K)
Business Context and Reporting Period
This Form 6-K, filed on August 1, 2024, announces the availability of Haleon Plc's half-year results for the period ended June 30, 2024. Haleon is a global leader in consumer health with a portfolio spanning Oral Health, Pain Relief, Respiratory Health, Digestive Health, and Vitamins, Minerals, and Supplements (VMS). Key brands include Advil, Sensodyne, Panadol, and Centrum.
Key Financial Metrics
The filing serves as a notification of results availability and does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. Investors are directed to the full results statement on the London Stock Exchange, the Haleon investor website, or the FCA National Storage Mechanism for detailed financial figures.
Material Changes and Dividend Declaration
- Dividend Increase: The Board declared a H1 2024 interim dividend of 2.0 pence per ordinary share, representing an 11% increase compared to the interim dividend in 2023.
- Payment Details: The dividend is expected to be paid on September 19, 2024, to shareholders on the register as of August 16, 2024.
- Ex-Dividend Dates: August 15, 2024, for ordinary shareholders and August 16, 2024, for US American Depositary Shares (ADS).
Guidance, Outlook, and Management Commentary
Management reaffirmed its guidance to grow the ordinary dividend at least in line with adjusted earnings, subject to market conditions and Board approval. A recorded results presentation and Q&A session with CEO Brian McNamara and CFO Tobias Hestler were conducted on August 1, 2024. The filing does not provide specific text regarding risks, contingencies, or unusual items beyond the standard regulatory disclosure.
Key Facts for Investor Verification
- Verify the full H1 2024 financial performance metrics (revenue, profit, cash flow) in the detailed results statement linked in the filing.
- Confirm the 11% year-over-year increase in the interim dividend to 2.0 pence per share.
- Note the record date of August 16, 2024, and payment date of September 19, 2024, for dividend eligibility.
- Review the archived webcast for management's commentary on market conditions and strategic outlook.